Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries

Circulation: Cardiovascular Interventions

Volumn 7, Issue 6, 2014, Pages 813-820

  Mahfoud, Felix ^a   Tunev, Stefan ^b   Ruwart, Jennifer ^b   Schulz Jander, Daniel ^b   Cremers, Bodo ^a   Linz, Dominik ^a   Zeller, Thomas ^c   Bhatt, Deepak L ^a,d   Rocha Singh, Krishna ^e   Böhm, Michael ^a   Melder, Robert J ^b   Guzman, Luis A ^f  

^a SAARLAND UNIVERSITY   (Germany)

^b MEDTRONIC INC   (United States)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e ST JOHN'S HOSPITAL   (United States)

^f NONE

Author keywords

Hypertension resistant to conventional therapy; Renal artery obstruction; Renovascular hypertension

Indexed keywords

NORADRENALIN; ANTIHYPERTENSIVE AGENTS; NOREPINEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER ABLATION; CLINICAL OBSERVATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY ANGIOGRAPHY; KIDNEY DENERVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY STENT; RESISTANT HYPERTENSION; SWINE; SYMPATHETIC NERVE; ADVERSE EFFECTS; ANIMALS; BLOOD PRESSURE; BLOOD SUPPLY; CASE REPORT; COMPLICATION; DISEASE MODELS, ANIMAL; DRUG EFFECTS; ENDOVASCULAR PROCEDURES; HUMANS; HYPERTENSION, RENOVASCULAR; INNERVATION; INSTRUMENTATION; KIDNEY; METABOLISM; METHODS; MIDDLE AGED; PHYSIOPATHOLOGY; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; STENTS; SURGERY; SUS SCROFA; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATHETER ABLATION; DISEASE MODELS, ANIMAL; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; MALE; MIDDLE AGED; NOREPINEPHRINE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; STENTS; SUS SCROFA; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84924284639     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001506     Document Type: Article

References (19)

1. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361: 1953-1962.
2. George JC, White CJ. Renal artery stenting: Lessons from ASTRAL (Angioplasty and Stenting for Renal Artery Lesions). JACC Cardiovasc Interv. 2010;3: 786-787.
3. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370: 13-22.
4. Kumbhani DJ, Bavry AA, Harvey JE, de Souza R, Scarpioni R, Bhatt DL, Kapadia SR. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: A meta-analysis of randomized controlled trials. Am Heart J. 2011;161: 622-630.e1.
5. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32: 2851-2906.
6. Jaff MR, Bates M, Sullivan T, Popma J, Gao X, Zaugg M, Verta P; HERCULES Investigators. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: Results from the HERCULES trial. Catheter Cardiovasc Interv. 2012;80: 343-350.
7. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: One-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126: 2976-2982.
8. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet. 2010;376: 1903-1909.
9. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013;128: 132-140.
10. Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: The EnligHTN I trial. Eur Heart J. 2013;34: 2132-2140.
11. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383: 622-629.
12. Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J. 2014;35: 1752-1759.
13. Mahfoud F, Lüscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, Doevendans P, Fagard R, Fajadet J, Komajda M, Lefèvre T, Lotan C, Sievert H, Volpe M, Widimsky P, Wijns W, Williams B, Windecker S, Witkowski A, Zeller T, Böhm M; European Society of Cardiology. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J. 2013;34: 2149-2157.
14. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C. ESH position paper: Renal denervation-an interventional therapy of resistant hypertension. J Hypertens. 2012;30: 837-841.
15. Ziegler AK, Franke J, Bertog SC. Renal denervation in a patient with prior renal artery stenting. Catheter Cardiovasc Interv. 2013;81: 342-345.
16. Bausback Y, Friedenberger J, Hertting K, Werner M, Branzan D, Freitas B, Piorkowski M, Schmidt A, Scheinert D. Renal denervation for hypertension refractory to renal artery stenting. J Endovasc Ther. 2014;21: 181-190.
17. Patel H, di Mario C. Microwaving metal! Can you get away with it? Renal denervation after stenting. Catheter Cardiovasc Interv. 2013;81: 346-347.
18. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheterbased renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet. 2009;373: 1275-1281.
19. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370: 1393-1401.